592 related articles for article (PubMed ID: 8275478)
1. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
2. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
3. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
Yang H; Chen ZJ; Kageshita T; Yamada M; Ferrone S
Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trial of anti-idiotypic monoclonal antibodies in advanced melanoma].
Kageshita T; Hirai S; Ono T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):163-9. PubMed ID: 8311486
[TBL] [Abstract][Full Text] [Related]
5. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
Chen ZJ; Yang H; Kageshita T; Ferrone S
Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513
[TBL] [Abstract][Full Text] [Related]
6. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
[TBL] [Abstract][Full Text] [Related]
7. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
Chen ZJ; Yang H; Ferrone S
J Immunol; 1991 Aug; 147(3):1082-90. PubMed ID: 1861071
[TBL] [Abstract][Full Text] [Related]
8. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
[TBL] [Abstract][Full Text] [Related]
9. Humoral antimelanoma immunity: induction by mouse antiidiotypic mAb, MK2-23 and association with survival of patients with advanced melanoma.
Mittelman A; Puccio C; Chun H; Ahmed T
Mt Sinai J Med; 1992 May; 59(3):234-7. PubMed ID: 1603113
[TBL] [Abstract][Full Text] [Related]
10. Antiantiidiotypic response and clinical course of the disease in patients with malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Wang X; Matsumoto K; Ferrone S
Hybridoma; 1995 Apr; 14(2):175-81. PubMed ID: 7590776
[TBL] [Abstract][Full Text] [Related]
11. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
12. Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies.
Kusama M; Kageshita T; Chen ZJ; Ferrone S
J Immunol; 1989 Dec; 143(11):3844-52. PubMed ID: 2584721
[TBL] [Abstract][Full Text] [Related]
13. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
Mittelman A; Chen ZJ; Yang H; Wong GY; Ferrone S
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):466-70. PubMed ID: 1731316
[TBL] [Abstract][Full Text] [Related]
14. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
Wang X; Ko EC; Peng L; Gillies SD; Ferrone S
Cancer Res; 2005 Aug; 65(15):6976-83. PubMed ID: 16061683
[TBL] [Abstract][Full Text] [Related]
15. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic MAb MK2-23. Immunohistochemical analysis of the reactivity of anti-anti-idiotypic MAb with surgically removed melanoma lesions.
Kageshita T; Hirai S; Ono T; Ferrone S
Int J Cancer; 1995 Jan; 60(3):334-40. PubMed ID: 7829240
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
17. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma.
Ferrone S; Chen ZJ; Liu CC; Hirai S; Kageshita T; Mittelman A
Pharmacol Ther; 1993; 57(2-3):259-90. PubMed ID: 8361995
[TBL] [Abstract][Full Text] [Related]
18. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
19. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
20. Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.
Mittelman A; Chen ZJ; Kageshita T; Yang H; Yamada M; Baskind P; Goldberg N; Puccio C; Ahmed T; Arlin Z
J Clin Invest; 1990 Dec; 86(6):2136-44. PubMed ID: 2254463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
